11. Centers for Disease Control. Locally acquired neurocysticercosis—North Carolina, Massachusetts, and South Carolina, 1989–1991. MMWR Morb Mortal Wkly Rep 1992;41:1–4. 12. Moore AC, Lutwick LI, Schantz PM, Pilcher JB, Wilson M, Hightower AW, et al. Seroprevalence of cysticercosis in an Orthodox Jewish commu- nity. Am J Trop Med Hyg 1995;53:439–42. 13. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis 1997;24:101–15. 14. Talan DA, Moran GJ, Mower WR, Newdow M, Ong S, Slutsker L, et al. EMERGEncy ID NET: An emergency department-based emerging infec- tions sentinel network. Ann Emerg Med 1998;32:703–11. 15. Tsang VCW, Brand JA, Boyer AE. An enzyme-linked immunoelec- trotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989;159:50–9. 16. Garcia HH, Gilman RH, Catacora M, Verastegui M, Gonzales AE, Tsang VCW, et al. Serological evolution of neurocysticercosis patients after antiparasitic therapy. J Infect Dis 1997;175:486–8. 17. Del Brutto OH, Wadia NH, Dumas M, Cruz M, Tsang VC, Schantz PM. Proposal of diagnostic criteria for human cysticercosis and neurocysticer- cosis. J Neurol Sci 1996;142:1–6. 18. Howard R. U.S. population boom to create real estate need. Los Angeles Times 1999 Nov 2. 19. Facts & figures (immigrants from Latin America; middle-class Hispan- ics) [brief report]. Hispanic 2001;14:16. 20. Alvarez F. Dawn of a new majority. Los Angeles Times 1999 Oct 17. RESEARCH 21. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unpro- voked seizures in Rochester, Minnesota: 1935–1984. Epilepsia 1993; 34:453–68. 22. Eisner RF, Turnbull TL, Howes DS, Gold IW. Efficacy of a “standard” seizure workup in the emergency department. Ann Emerg Med 1986;15:69–75. 23. Sempere AP, Villaverde FJ, Martinez-Menendez B, Cabeza C, Pena P, Tejerina JA. First seizure in adults: a prospective study from the emer- gency department. Acta Neurol Scand 1992;86:134–8. 24. Henneman PL, DeRoos F, Lewis RJ. Determining the need for admission in patients with new onset seizures. Ann Emerg Med 1994;24:1108–14. 25. Sorvillo FJ, Waterman SH, Richards FO, Schantz PM. Cysticercosis sur- veillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. Am J Trop Med Hyg 1992;47:365–71. 26. Dias MS, Carnevale F, Li V. Immediate posttraumatic seizures: is routine hospitalization necessary? Pediatr Neurosurg 1999;30:232–8. 27. Wiebe S, Bellhouse DR, Fallahay C, Eliasziw M. Burden of epilepsy: the Ontario health survey. Can J Neurol Sci 1999;26:263–70. 28. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelec- trotransfer blot in patients with neurocysticercosis. J Infect Dis 1991;164:1007–9. Address for correspondence: Samuel Ong, Dept. of Emergency Medicine, Olive View-UCLA Medical Center, 14445 Olive View Dr., North Annex, Syl- mar, CA 91342, USA; fax: 818-364-3268; e-mail: Samong@ucla.edu “Most of the fundamental ideas of science are essentially simple, and may, as a rule, be expressed in a language comprehensible to everyone.” Albert Einstein Emerging Infectious Diseases • Vol. 8, No. 6, June 2002 613